MUC5AC and cholangiocarcinoma: Further studies are needed to confirm that the secretion of MUC5AC glycoprotein may be modulated by treatment of CCA cells with BAs and to determine whether induction of MUC5AC by BAs can increase the invasion potential of cells in vitro and their metastatic potential in vivo [46].